Nuclear factor erythroid 2-related factor 1 divergent transcript (NFE2L1-DT)

NFE2L1 divergent transcript" (NFE2L1-DT) denotes an alternative transcript form of the NFE2L1 gene, best known for encoding the transcription factor Nuclear factor erythroid 2-related factor 1 (NFE2L1/NRF1)[1][3][5]. NFE2L1 is a CNC-bZIP family protein regulating oxidative stress response, proteasome biogenesis, and cell differentiation[4][5]. While multiple protein-coding transcript variants are well characterized (TCF11, NFE2L1ɑ, LCR-F1, NFE2L1γ, etc.), "NFE2L1-DT" is not an established protein isoform, functional molecule, or therapeutic target in current scientific literature or gene/protein databases. Its biological function and disease role remain undefined, and it is not used as a biomarker or drug target. The canonical NFE2L1 is implicated in cancer, neurodegenerative disease, and cellular stress regulation, but "Divergent Transcript" in this context may refer to uncharacterized non-coding RNA or alternative splicing with unclear significance. For future structured annotation, if the intention is to map "NFE2L1-DT" to a target in drug discovery or biomarker research, a review of transcript databases (e.g., Ensembl, GenBank) and specific non-coding RNA repositories would be warranted, but at present there is insufficient evidence to support "NFE2L1-DT" as a standard molecular target[5][7].

Other names

NFE2L1 divergent transcriptNFE2L1-DT